Broader spectrum

Japanese investors hope Prism's expansion beyond cancer will double valuation

Broader spectrum

Prism Pharma Co. Ltd. plans to use the $15 million it raised in a series C round last week to expand the Japanese company's focus beyond cancer and beef up its valuation.

New

Read the full 339 word article

How to gain access

Continue reading with a
two-week free trial.